Efficacy and safety of balovaptan for posttraumatic stress disorder: A randomized, placebo-controlled trial
{{output}}
Posttraumatic stress disorder (PTSD) has a significant impact on quality of life and affects more than 13 million individuals in the United States, with limited treatments available. EXUVIA (NCT05401565) was a Phase 2, randomized, placebo-controlled, double-bl... ...
